Information
Alpha-GPC (alpha-glycerylphosphorylcholine) is a choline compound that crosses the blood-brain barrier and raises brain acetylcholine levels. Most people take it for one of two reasons: sharper focus and mental performance before deep work, or a pre-workout bump in power output and growth hormone.
Mechanistically, Alpha-GPC donates its choline head group to make acetylcholine, the neurotransmitter that drives muscle contraction, attention, and memory formation. Unlike choline bitartrate, it actually gets into the brain in meaningful amounts, which is why it shows up in nootropic stacks and not just as a generic choline source. Acetylcholine also sits at the where the nerve meets the muscle, which is why Alpha-GPC has a legitimate claim on power output, not just cognition.
Deepdive
After oral ingestion, Alpha-GPC is hydrolyzed in the gut to free choline and glycerophosphate. The choline fraction enters the blood, crosses into the brain, and gets shuttled into cholinergic neurons where choline acetyltransferase converts it to acetylcholine. Plasma choline rises within 60 minutes of a standard dose and stays elevated for several hours. One study in healthy young men showed a single 1,000 mg dose raised plasma free choline by about 50% within an hour.
In healthy people, acute dosing produces measurable improvements on tasks that tax attention, processing speed, and working memory. A 2024 randomized crossover in resistance-trained men found that both 315 mg and 630 mg doses improved Stroop test performance versus placebo, with the higher dose also producing faster Flanker reaction times. An earlier trial comparing 200 mg Alpha-GPC to 200 mg caffeine and placebo in men and women found serial subtraction scores were 18% faster on Alpha-GPC than caffeine, with none of the jitteriness.
In clinical populations, the story is stronger. A 2023 systematic review and meta-analysis concluded that Alpha-GPC, alone or combined with donepezil, improved cognition, behavior, and daily function in patients with Alzheimer's, vascular dementia, and post-stroke cognitive impairment. The ASCOMALVA trial followed Alzheimer's patients on donepezil plus Alpha-GPC versus donepezil alone for two years and found the combination was superior on essentially every cognitive and functional measure. A 2024 Korean RCT in people with mild cognitive impairment using 600 mg daily for 12 weeks also showed benefit on the ADAS-cog scale.
A 6-day crossover trial at 600 mg/day produced a roughly 3% increase in isometric mid-thigh pull force, which is meaningful in strength sport. A 2008 study using a single 600 mg dose 90 minutes before resistance training found peak bench press force 14% greater than placebo, alongside a 44-fold spike in post-exercise growth hormone versus a 2.6-fold spike on placebo. The Parker crossover also saw vertical jump peak power roughly 8% higher on Alpha-GPC than placebo.
The growth hormone effect is dose-dependent and acute. Kawamura's 2012 study gave young men 1,000 mg and measured a roughly 290% increase in GH 60 minutes later, with a concurrent rise in free fatty acids and hepatic fat oxidation markers. This is a transient pulse, not a sustained elevation, and longer-term dosing (8 weeks at 1,200 mg/day in overweight adults) has failed to show lasting GH changes.
For women specifically, a 2022 trial in overweight and obese women used 1,000 mg before sprint interval exercise and found faster recovery of heart rate variability and blood pressure post-exercise compared to placebo, suggesting a cardioprotective autonomic effect during hard training. Female data is thinner than male data across the board, but the available evidence suggests the cognitive and performance effects translate.
As a lifter the GH spike is marginal difference if any, the actual contribution to gains would be the attentional/neuromuscular piece. You show up to the session more locked in, mind-muscle connection feels tighter, you hit your target reps with slightly better form and intent. It's still not an anabolic in its own right.
Most of the performance studies are small (often n < 20), industry-funded, and use acute or short-term dosing. Some well-designed studies have failed to find cognitive or physical performance benefits in healthy people, which is why acute responses are often described as dose-sensitive and variable. And critically, the long-term safety signal is not clean (see side effects below).
Dosage
- Cognitive/nootropic use: 300-600 mg once daily, taken in the morning or 60-90 minutes pre-workout which is the window where acetylcholine peaks.
- There's no evidence athletes need to go above the general 600 mg pre-workout window, and pushing higher doses long-term amplifies the TMAO concern (below)
- no sex-specific dose adjustments.
- Cycling: given long-term cardiovascular concerns, many people cycle Alpha-GPC (e.g., 8-12 weeks on, 4 weeks off) rather than taking it chronically. For acute pre-workout or pre-cognitive-task use only, chronic daily dosing isn't necessary.
- Timing: take with food if you experience heartburn.
- Caffeine interaction: The cognitive effects are complementary (cholinergic plus adenosine antagonism), and Alpha-GPC blunts some of caffeine's jittery edge.
Here's what you can expect
Acutely, within 60-90 minutes of a 300-600 mg dose, most people notice a subtle lift in focus, mental sharpness, and the kind of clean, non-stimulated cognitive engagement that makes demanding tasks feel less effortful. Unlike caffeine, there's no racing heart or jitter. On training days, expect a slightly stronger mind-muscle connection and, anecdotally, better performance on compound lifts where neuromuscular coordination matters.
The growth hormone pulse after resistance training is transient and won’t contribute in any meaningful way.
In healthy high-performers, the effect is modest and sometimes within the noise of day-to-day variation.
Some people feel nothing. Try it 3-5 times at 300-600 mg, 60 minutes before a demanding task, and compare to how you normally feel on similar tasks. If you notice nothing across several trials, it's probably not doing much for you.
Side effects & risks
Short-term side effects are mild and uncommon: heartburn, headache, nausea, mild dizziness, and occasionally vivid dreams or insomnia if dosed late in the day. Human trials up to 1,200 mg/day for 6 months have not reported serious adverse events.
Cardiovascular health: Alpha-GPC is a choline compound, and gut bacteria convert choline to TMAO (trimethylamine-N-oxide), a metabolite linked to atherosclerosis, endothelial dysfunction, and stroke risk in humans. Mouse feeding studies show Alpha-GPC directly promotes atherosclerotic lesion development. Human data is messier, a 2021 Korean cohort study of 12 million adults found elevated stroke risk in long-term Alpha-GPC users with a dose-response pattern, while a 2025 follow-up in people with mild cognitive impairment found the opposite. The signal isn't settled, but the mechanism is real.
Direct feeding studies in mice show Alpha-GPC significantly raises plasma TMAO and accelerates atherosclerotic lesion development through multiple pathways, including direct endothelial MAPK and NF-κB activation independent of TMAO. Alpha-GPC also raised TMAO more than phosphatidylcholine in rodent comparisons, suggesting the free-choline-like behavior of Alpha-GPC in the gut is the problem.
If you have cardiovascular risk factors (hypertension, high LDL, atherosclerosis, family history of stroke), Alpha-GPC is probably not the right choline source. If you're using it, cycling rather than chronic daily use is prudent. Co-supplements that may attenuate TMAO production (garlic extract, berberine, and a generally fiber-rich diet that shifts the microbiome) are plausible mitigations, though evidence that they offset Alpha-GPC's TMAO signal specifically is limited.
Interactions: Alpha-GPC may reduce the effectiveness of scopolamine and other anticholinergics. It's synergistic with acetylcholinesterase inhibitors like donepezil but should be coordinated with a prescribing clinician if you're on one.
Blood markers
Baseline (before starting): standard lipid panel (LDL, HDL, triglycerides, ApoB), hs-CRP, and blood pressure. If you have any cardiovascular risk factors or plan to use Alpha-GPC chronically, also get a baseline TMAO level. Recheck at 8-12 weeks
OTC in most countries. The FDA determined that intake of no more than 196.2 mg/person/day is considered generally recognized as safe.
Made with Bullet